| Professional Services Industry | Industrials Sector | Mr. John Hogg CMILT CEO | CXA Exchange | - ISIN |
| Australia Country | 25 Employees | - Last Dividend | - Last Split | - IPO Date |
Cryosite Limited is a specialized provider of outsourced clinical trials logistic services based in Australia. Established in 1999 and headquartered in South Granville, Australia, the company operates across two primary segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. Cryosite serves a diverse range of industries, including research, medical, pharmaceutical, and biotechnology, offering a variety of services tailored to the needs of the clinical trials, research, and pharmaceutical sectors. By focusing on reliable and advanced logistic solutions, Cryosite has positioned itself as a critical partner for organizations seeking specialized storage and logistic services in the healthcare and biotechnological fields.
Under this segment, Cryosite offers extensive logistic services tailored to the clinical trials, research, and pharmaceutical industries. This includes specialist temperature-controlled storage to ensure the integrity of sensitive materials. The company also provides sourcing, labelling, and secondary packaging services, which are crucial for the safe and secure transportation of clinical materials. Status management and schedule drug distribution services ensure timely and efficient delivery of medical products, while destruction and returns processes handle the disposal and return of clinical trial materials. Additionally, Cryosite extends its biological logistics services, supporting the complex needs of biological transportation and storage with proficiency.
This segment caters to the need for long-term storage solutions for cord blood and tissue samples. Cryosite’s dedicated storage facilities are designed to maintain the viability of these samples for future medical or research purposes, leveraging advanced technology and stringent safety measures to ensure the preservation of these critical biological materials. This service is particularly vital for families and individuals looking to store stem cells and other tissues for potential future health treatments, providing a form of biological insurance against certain medical conditions.